42 results on '"Schetelig, Johannes"'
Search Results
2. Allogeneic hematopoietic stem-cell transplantation for patients with Richter transformation: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT
3. Harmonizing definitions for hematopoietic recovery, graft rejection, graft failure, poor graft function, and donor chimerism in allogeneic hematopoietic cell transplantation: a report on behalf of the EBMT, ASTCT, CIBMTR, and APBMT
4. Mimicking clinical trials with synthetic acute myeloid leukemia patients using generative artificial intelligence
5. Tislelizumab plus zanubrutinib for Richter transformation: the phase 2 RT1 trial
6. The role of anti-thymocyte globulin in allogeneic stem cell transplantation (HSCT) from HLA-matched unrelated donors (MUD) for secondary AML in remission: a study from the ALWP /EBMT
7. Mutated IKZF1 is an independent marker of adverse risk in acute myeloid leukemia
8. Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia – implications for the European LeukemiaNet risk classification
9. Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: final report of BMT CTN 2002
10. UBTF tandem duplications are rare but recurrent alterations in adult AML and associated with younger age, myelodysplasia, and inferior outcome
11. Unsupervised meta-clustering identifies risk clusters in acute myeloid leukemia based on clinical and genetic profiles
12. Alterations of cohesin complex genes in acute myeloid leukemia: differential co-mutations, clinical presentation and impact on outcome
13. Potential of TCR sequencing in graft-versus-host disease
14. Klonale Hämatopoese – Bedeutung für die Zelltherapie
15. Analysis of survival outcomes in haematopoietic cell transplant studies: Pitfalls and solutions
16. Fascia training in patients undergoing allogeneic hematopoietic cell transplantation—a pilot study
17. Deep learning detects acute myeloid leukemia and predicts NPM1 mutation status from bone marrow smears
18. Deep learning identifies Acute Promyelocytic Leukemia in bone marrow smears
19. Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation
20. Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations
21. Clonal hematopoiesis and its emerging effects on cellular therapies
22. A multicenter prospective, randomized, placebo-controlled phase II/III trial for preemptive acute graft-versus-host disease therapy
23. Stem cell donor registry activities during the COVID-19 pandemic: a field report by DKMS
24. Idelalisib treatment prior to allogeneic stem cell transplantation for patients with chronic lymphocytic leukemia: a report from the EBMT chronic malignancies working party
25. Allogeneic hematopoietic cell transplantation for patients with TP53 mutant or deleted chronic lymphocytic leukemia: Results of a prospective observational study
26. Salvage treatment with plerixafor in poor mobilizing allogeneic stem cell donors: results of a prospective phase II-trial
27. Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia
28. The clinical mutatome of core binding factor leukemia
29. Clostridium Difficile infections in patients with AML or MDS undergoing allogeneic hematopoietic stem cell transplantation identify high risk for adverse outcome
30. Modified DHAP regimen in the salvage treatment of refractory or relapsed lymphomas
31. Correction to: Idelalisib treatment prior to allogeneic stem cell transplantation for patients with chronic lymphocytic leukemia: a report from the EBMT chronic malignancies working party
32. Correction to: Salvage treatment with plerixafor in poor mobilizing allogeneic stem cell donors: results of a prospective phase II-trial
33. Correction to: Allogeneic hematopoietic cell transplantation for patients with TP53 mutant or deleted chronic lymphocytic leukemia: results of a prospective observational study
34. Late treatment-related mortality versus competing causes of death after allogeneic transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia
35. Ibrutinib for bridging to allogeneic hematopoietic cell transplantation in patients with chronic lymphocytic leukemia or mantle cell lymphoma: a study by the EBMT Chronic Malignancies and Lymphoma Working Parties
36. Correction: Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey
37. Lysyl oxidase expression is associated with inferior outcome and Extramedullary disease of acute myeloid leukemia
38. Clonal hematopoiesis in patients with multiple myeloma undergoing autologous stem cell transplantation
39. Outcomes of haploidentical stem cell transplantation for chronic lymphocytic leukemia: a retrospective study on behalf of the chronic malignancies working party of the EBMT
40. Using efference copy and a forward internal model for adaptive biped walking
41. T cell-mediated graft-versus-leukemia reactions after allogeneic stem cell transplantation
42. Use of rasburicase in a pregnant woman with acute lymphoblastic leukaemia and imminent tumour lysis syndrome
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.